YOKOGAWA-ELECTRIC
Yokogawa Electric Corporation (TOKYO: 6841) announces that on March 20, 2020, it completed the acquisition of all shares in Denmark-based Grazper Technologies ApS (Grazper), as mutually agreed. Grazper has developed advanced artificial intelligence (AI) technologies for analyzing images, and Yokogawa aims to leverage these technologies within its various existing businesses and to develop new industrial AI solutions.
Recent advances in deep learning and related technologies have enabled the practical application of AI in industry, and it is expected that as image identification and data forecasting accuracy continue to improve, the use of AI will only expand further. In particular, by improving the recognition accuracy for moving imagery, it becomes possible to observe the overall environment and context of the whole image, opening up new applications in the security field and for image analysis and robot operations on production lines.
Grazper is a venture company founded in Copenhagen, Denmark in 2015, and later funded by Danish venture capital firm Promentum Equity Partners. It possesses advanced AI-based technologies for image analysis, and one notable strength is a solution that allows AI software to run efficiently on a field-programmable gate array (FPGA*), a type of integrated circuit. The software employs image recognition methodologies that have been theorized using algorithms and 3D modeling, and it can be operated with limited computing resources.
Yokogawa is developing and providing AI-based solutions for plants and public infrastructure projects. Acquiring Grazper’s technology will enable the company to provide solutions that use AI for image analysis, such as capturing image information for robots, detecting abnormalities at plants, and monitoring security using cameras. As a first step, Yokogawa’s subsidiary, amnimo Inc., will embed Grazper's FPGA IP core into its Edge Gateway industrial LTE gateway, which is currently under development. This will make possible solutions for smart city projects and security applications targeting airports and railways.
As part of Yokogawa’s Transformation 2020 mid-term business plan, the company is working with customers on digital transformation initiatives that utilize technologies such as AI and IoT. Through this acquisition and the addition of new technology, Yokogawa will create new value by co-innovating with customers.
* A device that allows the immediate rewriting of the logic circuit design in the hardware language
Outline of Grazper Technologies ApS
Location: Copenhagen, Denmark
Founded: April 2015
CEO: Thomas Jakobsen
Business domain: Development of AI technologies and solutions that utilize imagery
Website: https://grazper.com/
For more information
amnimo Inc. website: https://amnimo.com/en/
About Yokogawa
Founded in 1915, Yokogawa engages in broad-ranging activities in the areas of measurement, control, and information. The industrial automation business provides vital products, services, and solutions to a diverse range of process industries including oil, chemicals, natural gas, power, iron and steel, and pulp and paper. With the life innovation business, the company aims to radically improve productivity across the pharmaceutical and food industry value chains. The test & measurement, aviation, and other businesses continue to provide essential instruments and equipment with industry-leading precision and reliability. Yokogawa co-innovates with its customers through a global network of 113 companies spanning 60 countries, generating US$3.6 billion in sales in FY2018. For more information, please visit www.yokogawa.com .
The names of corporations, organizations, products, services and logos herein are either registered trademarks or trademarks of Yokogawa Electric Corporation or their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200324005287/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ASISA Partners with HCLTech to Drive Digital Transformation and Expansion in Iberia17.6.2025 13:41:00 CEST | Press release
HCLTech, a leading global technology company, has been selected by ASISA, a prominent health insurance provider in Spain, as its strategic IT partner to accelerate business transformation and expansion in Iberia. This partnership aims to accelerate ASISA's digital transformation journey to enhance the experience for its 2.2 million customers and position the company at the forefront of innovation in the region. HCLTech will modernize ASISA's IT platforms and leverage AI-based solutions to enhance business efficiency. The comprehensive mainframe modernization and solutions from HCLTech will enable ASISA to create a more agile, responsive IT infrastructure. “Partnering with HCLTech marks a key step in our digital transformation journey. By modernizing our platforms and embracing cutting-edge technologies, we are reinforcing our commitment to delivering exceptional service to our customers,” said José Pereira, CTO at ASISA. “This collaboration will empower ASISA with a more agile, scalabl
Biocytogen Responds to Harbour BioMed’s Patent Claims: RenNano® is an Independently Developed Platform with Distinct Innovation and Full Legal Standing17.6.2025 13:00:00 CEST | Press release
In response to Harbour BioMed’s recent press release regarding a procedural development in their ongoing legal claim, Biocytogen issues the following statement: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617098086/en/ Figure 1. Biocytogen’s RenNano® Platform Genetic Engineering Strategy (Source: https://biocytogen.com/antibody-drug-development/rennano） Biocytogen stands by its core values of independent innovation, respect for intellectual property, and a commitment to fair competition. The RenNano® platform is the result of independent, original R&D, based on Biocytogen’s proprietary genome editing technologies. Its technical principles, design strategy, and IP scope are fundamentally different from the patents in dispute. 120 vs. 9 – A Significant Technical Divide of RenNano® Platform; Biocytogen Will Resolutely Take Legal Actions to Protect Its Rights The RenNano® platform employs a large-fragment knock-in strategy
EDB Postgres® AI Accelerates New Era of Sovereign Data and AI for Enterprises, Industries, and Nations17.6.2025 13:00:00 CEST | Press release
The first secure Postgres platform that unifies transactional, analytical, and AI—democratizing agentic AI across hybrid environments through an easy-to-use interface EDB introduces new capabilities to the industry’s first Postgres-based data and AI platform, allowing enterprises to easily manage, observe, and democratize the use of agentic AI within a sovereign setting. Only 13% of enterprises globally have successfully deployed a broad set of agentic AI applications at scale, according to EDB research (May 2025). These early leaders are seeing dramatically better returns—up to 227% higher ROI than the remaining 87%, and 23% better ROI than the next-best group—so this launch is essential for businesses who want to come out on top in the AI race. EDB Postgres AI transforms core operational data into an AI-ready asset, with just five lines of code to set up an AI pipeline that automatically syncs embeddings with source data, taking AI from concept to production 3x faster while cutting c
G42 and Liquid AI Partner to Deliver Private, Local and Efficient AI Solutions to Enterprises at Scale17.6.2025 12:00:00 CEST | Press release
G42, the Abu Dhabi-based global technology group, and Liquid AI, a leading efficient foundation models company headquartered in Cambridge, Massachusetts, today announced that they have entered into a multifaceted commercial partnership to facilitate the creation, training and commercialization of generative AI solutions powered by Liquid Foundation Models. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617744482/en/ The goal of the partnership is to jointly develop and deploy private generative AI solutions internationally, from the Middle East and North Africa to the Global South, and across many sectors, such as investment and banking, consumer electronics, telecommunications, biotech, and energy. G42 companies such as Core42 and Inception are involved in various aspects of the partnership, from AI infrastructure for AI development to co-designing multimodal foundation models and deployment. “This partnership reflects o
Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)17.6.2025 10:28:00 CEST | Press release
Ferrer, a B Corp-certified international pharmaceutical company, has announced that FNP-223, a novel therapy in-licensed from Asceneuron and aimed at slowing the development of progressive supranuclear palsy (PSP), has received Fast Track designation from the US Food & Drug Administration (FDA). FNP-223, a new molecular entity in active development for PSP, is in an ongoing Phase 2 study to evaluate its safety, efficacy, and pharmacokinetics in adult patients with possible or probable PSP-Richardson syndrome (PSP-RS), the most common clinical variant of this neurodegenerative disease1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617437460/en/ Ferrer's pharmaceutical production plant in Sant Cugat del Vallés, Barcelona, Spain. “We are thrilled to receive Fast Track designation from the FDA for FNP-223 in the treatment of PSP. Consistent with our purpose of using business to fight for social justice, we are committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom